All the news Showing 10 of 22 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources COVID-19 vaccine responses are weaker in liver transplant patients Keith Alcorn / 08 July 2021 Liver transplant recipients in Israel were less likely to develop antibodies after a second dose of the Pfizer SARS-CoV-2 vaccine than healthy volunteers, transplant specialists from Tel Aviv’s Sourasky Medical Center report in ... Liver transplant outcomes improve in people with HIV and hepatitis C Keith Alcorn / 21 June 2021 Survival after a liver transplant has improved significantly in people with HIV and hepatitis C co-infection since the introduction of direct-acting antiviral treatment for hepatitis C, US researchers report in the journal Transplantation ... International registries provide more information about COVID-19 and liver disease Liz Highleyman / 17 September 2020 People with advanced liver cirrhosis are more likely to develop severe COVID-19 complications and to die from it, but those who have received liver transplants do not appear to be at greater ... NASH is fastest-growing reason for a liver transplant in United States Keith Alcorn / 22 June 2020 Non-alcoholic steatohepatitis (NASH), the severe form of non-alcoholic fatty liver disease (NAFLD), is now the most common reason for a liver transplant in women, older patients and people receiving Medicare insurance in the ... Liver transplants and COVID-19 Keith Alcorn / 28 April 2020 Liver specialists in New York report a high frequency of severe COVID-19 cases in organ transplant recipients who became infected with SARS-CoV-2, while Italian specialists report that 15 of 17 patients who underwent ... Liver specialists offer guidance on COVID-19 risks in liver patients Keith Alcorn / 25 March 2020 The American Association for the Study of Liver Diseases (AASLD) has issued preliminary guidance for liver specialists on managing COVID-19 in patients with liver disease, based on data published up to late March. COVID-19 ... Need for liver transplants due to hepatitis C drops in United Kingdom Keith Alcorn / 22 October 2018 Registrations for liver transplants due to complications of hepatitis C infection in the United Kingdom fell sharply between 2013 and 2016, coinciding with the gradual increase in availability of direct-acting antiviral treatment, researchers ... What support do people with liver cirrhosis and their families need? Keith Alcorn / 09 October 2018 People with liver cirrhosis and their families need more information about their condition and prognosis and greater access to palliative care, a systematic review of studies on the needs of people with cirrhosis ... Advent of DAAs accompanied by dramatic improvement in survival after HCV-related liver transplant Michael Carter / 18 July 2018 Survival among people with hepatitis C virus (HCV) undergoing liver transplant has improved significantly since the introduction of direct-acting antivirals (DAAs), investigators from Catalonia report in the Journal of Hepatology. Thanks to DAAs, there ... Direct-acting antivirals bring fewer HCV-related liver transplants, better survival after transplantation, in Europe Michael Carter / 16 April 2018 There has been a steep fall in the number of hepatitis C virus (HCV)-related liver transplants since the introduction of direct-acting antivirals (DAAs), according to European research presented to the ... ← First123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive